Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06895603 · ClinicalTrials.gov registry record

The HIgh-fidelity Hydraulic couPling Upper-arm Cuff Assessment of Limits, Safety, and Effectiveness (HIPULSE) Trial (Cardiac Output Study)

A clinical trial of ICU and Pulmonary Artery Catheter (PAC), sponsored by Philips Clinical & Medical Affairs Global.

Recruiting
Registry status
75
Enrollment target
2
Study locations

NCT06895603 is a study of ICU and Pulmonary Artery Catheter (PAC) that is actively recruiting participants, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 75 participants, below the 207-participant average among 3 other ICU trials with a reported enrollment target (64% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06895603, a study of ICU and Pulmonary Artery Catheter (PAC), is actively recruiting participants, sponsored by Philips Clinical & Medical Affairs Global.

RECRUITING
Registry status
75 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to compare cardiac output (CO), fluid responsiveness, and related measurements between the Philips AMC and PAC (Swan-Ganz) in ICU or surgical patients.

Interventions

  • DEVICE Philips Advanced Monitoring Cuff (AMC)

Study Locations (2)

Virginia

  • UVA Health - Charlottesville

Hamburg

  • Universitätsklinikum Hamburg Eppendorf - Hamburg

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2025-10-28
Est. Completion 2026-06

What the Registry Record Tells You About NCT06895603

The ClinicalTrials.gov registry entry for NCT06895603 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 207-participant average among 3 other ICU trials with a reported enrollment target (64% lower). The listed sponsor is Philips Clinical & Medical Affairs Global, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with ICU appearing as the primary indexed condition, and to 1 intervention - of which Philips Advanced Monitoring Cuff (AMC) is the first listed.

NCT06895603 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Virginia, Hamburg.

Frequently Asked Questions

What is clinical trial NCT06895603 about?

NCT06895603 is a clinical study titled "The HIgh-fidelity Hydraulic couPling Upper-arm Cuff Assessment of Limits, Safety, and Effectiveness (HIPULSE) Trial (Cardiac Output Study)". The purpose of this study is to compare cardiac output (CO), fluid responsiveness, and related measurements between the Philips AMC and PAC (Swan-Ganz) in ICU or surgical patients.

What is the current status of trial NCT06895603?

This trial is currently recruiting. The enrollment target is 75 participants. The study started on 2025-10-28. Estimated completion is 2026-06.

What conditions does trial NCT06895603 study?

This clinical trial studies the following conditions: ICU, Pulmonary Artery Catheter (PAC), Swan-Ganz Catheter.

What interventions are being tested in trial NCT06895603?

The interventions under investigation include: Philips Advanced Monitoring Cuff (AMC) (DEVICE).

Who is sponsoring clinical trial NCT06895603?

This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06895603 being conducted?

This trial has 2 study locations across Virginia, Hamburg. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ICU

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.